Follow
Pranita D. Tamma, MD, MHS
Pranita D. Tamma, MD, MHS
Johns Hopkins University School of Medicine
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
Combination therapy for treatment of infections with gram-negative bacteria
PD Tamma, SE Cosgrove, LL Maragakis
Clinical microbiology reviews 25 (3), 450-470, 2012
8822012
Association of adverse events with antibiotic use in hospitalized patients
PD Tamma, E Avdic, DX Li, K Dzintars, SE Cosgrove
JAMA internal medicine 177 (9), 1308-1315, 2017
6102017
Infectious Diseases Society of America guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales …
PD Tamma, SL Aitken, RA Bonomo, AJ Mathers, D Van Duin, CJ Clancy
Clinical Infectious Diseases 72 (7), e169-e183, 2021
5222021
Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae bacteremia
PD Tamma, KE Goodman, AD Harris, T Tekle, A Roberts, A Taiwo, ...
Clinical Infectious Diseases 64 (3), 257-264, 2017
3762017
Safety of influenza vaccination during pregnancy
PD Tamma, KA Ault, C del Rio, MC Steinhoff, NA Halsey, SB Omer
American journal of obstetrics and gynecology 201 (6), 547-552, 2009
3712009
Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and …
PD Tamma, SL Aitken, RA Bonomo, AJ Mathers, D Van Duin, CJ Clancy
Clinical Infectious Diseases 74 (12), 2089-2114, 2022
3702022
Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia
PD Tamma, JH Han, C Rock, AD Harris, E Lautenbach, AJ Hsu, E Avdic, ...
Clinical Infectious Diseases 60 (9), 1319-1325, 2015
3632015
Multicenter initial guidance on use of antivirals for children with coronavirus disease 2019/severe acute respiratory syndrome coronavirus 2
K Chiotos, M Hayes, DW Kimberlin, SB Jones, SH James, SG Pinninti, ...
Journal of the Pediatric Infectious Diseases Society 9 (6), 701-715, 2020
3132020
Phenotypic detection of carbapenemase-producing organisms from clinical isolates
PD Tamma, PJ Simner
Journal of clinical microbiology 56 (11), 10.1128/jcm. 01140-18, 2018
2492018
Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant …
PD Tamma, SL Aitken, RA Bonomo, AJ Mathers, D Van Duin, CJ Clancy
Clinical Infectious Diseases 75 (2), 187-212, 2022
2472022
Antimicrobial stewardship
PD Tamma, SE Cosgrove
Infectious Disease Clinics 25 (1), 245-260, 2011
2342011
A primer on AmpC β-lactamases: necessary knowledge for an increasingly multidrug-resistant world
PD Tamma, Y Doi, RA Bonomo, JK Johnson, PJ Simner, ...
Clinical Infectious Diseases 69 (8), 1446-1455, 2019
2272019
What is the more effective antibiotic stewardship intervention: preprescription authorization or postprescription review with feedback?
PD Tamma, E Avdic, JF Keenan, Y Zhao, G Anand, J Cooper, R Dezube, ...
Clinical Infectious Diseases 64 (5), 537-543, 2017
1992017
Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections
PD Tamma, SL Aitken, RA Bonomo, AJ Mathers, D van Duin, CJ Clancy
Clinical Infectious Diseases, ciad428, 2023
1912023
Treatment of multidrug-resistant Gram-negative infections in children
AJ Hsu, PD Tamma
Clinical infectious diseases 58 (10), 1439-1448, 2014
1892014
The use of noncarbapenem β-lactams for the treatment of extended-spectrum β-lactamase infections
PD Tamma, J Rodriguez-Baňo
Clinical Infectious Diseases 64 (7), 972-980, 2017
1882017
Considerations for the use of phage therapy in clinical practice
GA Suh, TP Lodise, PD Tamma, JM Knisely, J Alexander, S Aslam, ...
Antimicrobial agents and chemotherapy 66 (3), e02071-21, 2022
1742022
Comparing the outcomes of adults with Enterobacteriaceae bacteremia receiving short-course versus prolonged-course antibiotic therapy in a multicenter, propensity score–matched …
D Chotiprasitsakul, JH Han, SE Cosgrove, AD Harris, E Lautenbach, ...
Clinical infectious diseases 66 (2), 172-177, 2018
1732018
The use of cefepime for treating AmpC β-lactamase–producing Enterobacteriaceae
PD Tamma, SCT Girdwood, R Gopaul, T Tekle, AA Roberts, AD Harris, ...
Clinical infectious diseases 57 (6), 781-788, 2013
1732013
A clinical decision tree to predict whether a bacteremic patient is infected with an extended-spectrum β-lactamase–producing organism
KE Goodman, J Lessler, SE Cosgrove, AD Harris, E Lautenbach, JH Han, ...
Clinical Infectious Diseases 63 (7), 896-903, 2016
1662016
The system can't perform the operation now. Try again later.
Articles 1–20